Active Share (vs S&P 500): 98.0%
· vs QQQ: 99.7%
— share of the book that differs from index weights (higher = more active)
· ranking
Est. Qtr Return (Q2 2026 → Q3 2026):
-11.7%
· vs SPY
-13.8%
· Prev Value $1.88B
— last quarter positions weighted by this quarter price moves
· ranking
Est. QTD Return (Q3 2026 → newest close):
+0.9%
· vs SPY
-1.3%
· Latest Value $2.21B
— latest reported positions valued at quarter-to-date price moves (still in progress)
· ranking
In its Q3 2026 13F filing, Sofinnova Investments, Inc. disclosed 63 equity positions with a combined reported value of $2.21B. The filing implies a focused portfolio: its ten largest positions account for 65.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were NTRA ($640.75M), GMAB ($155.17M), IWM ($138.94M). By sector, the heaviest allocations are Health Care 91.2%, Other 8.8%. Versus the prior quarter, allocation shifted toward Other (+8.8pp) and away from Health Care (-8.8pp).
Versus the prior quarter, Sofinnova Investments, Inc. opened 18 new positions, trimmed 21 and fully exited 11, a turnover rate of 67.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.
The largest new positions opened in Q3 2026 were IWM ($138.94M), AZN ($61.85M), QQQ ($55.48M).
Of the 11 positions fully exited versus the prior quarter, the largest were SUPN ($48.20M), GILD ($43.35M), COGT ($40.06M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
Client mix (by RAUM): pension and profit-sharing plans 100%
Manages 7 private funds, of which 3 hedge funds
Website: sofinnova.com
Portfolio Structure
56 positions · $1.88B reported value (Q2 2026)
Top 10 holdings = 59.2% of reported value
Largest position: NTRA (NATERA INC) at 22.4%
Average position size: $33.52M
Sector Tilt
Health Care 100.0%
(classified holdings cover 100% of value)
Quarterly Activity
Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
13 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Every 13F share count is marked to the quarter-end close, rebuilding the NAV this
portfolio would have earned had it done nothing all quarter. This is a historical
reconstruction from already-public filings and prices — not a model forecast, so
precision/recall do not apply.
2024-Q2 = 100. Solid = reconstructed NAV, dashed = SPY benchmark.
Prices are split-adjusted closes and exclude dividends, so dividend-heavy
portfolios would in reality sit slightly above this line.
This portfolio is broadly diversified (Top-10 = 56.7% of reported value), so a
Top-10 proxy cannot represent the whole fund — only the full-holdings reconstruction is shown.
Why there is no forecast NAV
Not published because:
Top-10 covers < 85% of reported value · Holdings-forecast backtest F1 < 0.80 · Top-10 quarterly turnover > 20%
Source: full 13F positions marked to quarter-end closes (computed 2026-11-02 01:13:11).
Share counts and prices are used as a ratio, so splits cancel out.
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical
trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative
volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through
quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 40%R 40%F1 40%(modelled on 2026-Q1; 4/10 hit)
Low-confidence forecast
This fund replaces about 48% of its Top-10 each quarter and
backtests at F1 49% (threshold 80%).
Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.
KRTX · RYZB · MRK · ASND · NTRA · AVTE · IDYA · VERA · AZN · IMGN
NTRA · VERA · ASND · AVTE · MRK · XBI · NVO · INCY · ARGX · ISRG
2024-Q2
50%
50%
50%
NTRA · VERA · ASND · AVTE · MRK · INCY · XBI · NVO · ARGX · DYN
QQQ · NTRA · VERA · ASND · NVO · SYK · AZN · DYN · ALGN · EW
2024-Q3
40%
40%
40%
QQQ · NTRA · ASND · VERA · NVO · SYK · AZN · DYN · ALGN · SNDX
NTRA · VERA · NVO · AZN · IDYA · ELAN · BIOA · INCY · RAPP · AVBP
2024-Q4
40%
40%
40%
NTRA · VERA · NVO · AZN · IDYA · ELAN · INCY · BIOA · RAPP · AVBP
NTRA · VERA · GILD · ABBV · JAZZ · SRPT · AVBP · AZN · SYK · REPL
2025-Q1
50%
50%
50%
NTRA · VERA · GILD · JAZZ · ABBV · SRPT · SYK · AVBP · REPL · AZN
NTRA · SYK · QQQ · IWM · VERA · JAZZ · MDT · ALNY · GILD · LLY
2025-Q2
50%
50%
50%
NTRA · SYK · QQQ · IWM · JAZZ · VERA · ALNY · MDT · LLY · IDYA
NTRA · GILD · LLY · JAZZ · VERA · IWM · ABBV · IBB · BSX · DXCM
2025-Q3
60%
60%
60%
NTRA · GILD · LLY · JAZZ · VERA · IWM · BSX · IDYA · DXCM · BBIO
NTRA · GILD · VERA · JAZZ · AZN · RAPP · BSX · DXCM · ISRG · AXSM
2025-Q4
50%
50%
50%
NTRA · GILD · VERA · JAZZ · AZN · BSX · RAPP · DXCM · ISRG · AXSM
NTRA · JAZZ · AZN · VERA · BMY · UTHR · VRTX · ABBV · ISRG · COGT
2026-Q1
60%
60%
60%
NTRA · JAZZ · AZN · VERA · BMY · VRTX · UTHR · ISRG · COGT · ABBV
NTRA · IWM · XBI · BMY · JAZZ · VERA · AZN · QQQ · COGT · IBB
2026-Q2 ★
40%
40%
40%
NTRA · IWM · XBI · BMY · JAZZ · VERA · AZN · IBB · COGT · QQQ
NTRA · VERA · GMAB · JAZZ · RAPP · SPTX · AVBP · BIOA · BMY · SUPN
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
Barra Factor Attribution
The disclosed long US equity book from the 2026-Q3 13F is held at its
report-date weights and decomposed over 2026-09-30 ~ 2026-11-13.
The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional
factor returns and an EWMA factor covariance for risk. The “portfolio” is the
visible 13F book, not the fund's true NAV.
The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.
Portfolio return-13.47%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+0.25%vs benchmark
Barra annualised vol40.9%Model estimate
Realised vol38.3%Annualised in window
Weighted beta0.89Raw exposure
Factor / specific risk41% / 59%Share of variance
Top-10 concentration96.8%Of reported value
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.
1. Performance
Metric
Value
Note
Portfolio return (buy & hold)
-13.47%
Disclosed long book
QQQ synthetic benchmark
-13.72%
Liquidity-weighted constituents
Model universe, equal weight
+0.30%
Opportunity-cost reference
Excess return
+0.25%
Portfolio − benchmark
Arithmetic return sum
-13.50%
Difference vs compounded is the cross term
Weighted raw beta
0.89
Weighted holding betas
Realised volatility (annualised)
38.31%
Daily returns in window
Barra model volatility (annualised)
40.95%
Factor + specific
Factor share of variance
41.4%
Barra factors
Specific share of variance
58.6%
Stock residuals
Reported value
$1.13B
13F long US equity
2. Return attribution
The -13.50% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.
Factor group
Factors
Contribution
Share of |return|
Size & Liquidity
6
+3.65%
27.0%
Momentum & Growth
3
-2.33%
-17.2%
Volatility & Tail Risk
7
-3.85%
-28.5%
Industry
12
+8.45%
62.6%
Specific
1
-19.43%
-143.9%
Factor
Type
Exposure
Factor return
Contribution
Share of |return|
Kurtosis
Style
+2.19
+6.97%
+15.24%
112.9%
Health Care
Industry
+0.83
+8.12%
+6.73%
49.8%
Turnover
Style
-0.58
-4.77%
+2.76%
20.4%
Growth
Style
+1.76
+1.57%
+2.75%
20.4%
Other
Industry
+0.17
+10.06%
+1.73%
12.8%
Leverage (Downside Vol)
Style
-0.89
-1.82%
+1.63%
12.1%
Non-linear Size
Style
+0.99
+0.91%
+0.91%
6.7%
Size
Style
-0.28
-1.83%
+0.52%
3.8%
Liquidity
Style
+1.28
+0.22%
+0.28%
2.0%
Beta
Style
+0.03
+4.85%
+0.15%
1.1%
Amihud Illiquidity
Style
+0.73
-0.40%
-0.29%
-2.2%
Mid Cap
Style
+0.30
-1.69%
-0.51%
-3.8%
Short-term Reversal
Style
-1.69
+0.79%
-1.33%
-9.8%
Residual Volatility
Style
-0.56
+2.66%
-1.50%
-11.1%
Max Drawdown
Style
+0.96
-1.96%
-1.87%
-13.9%
Momentum
Style
+1.12
-3.34%
-3.75%
-27.8%
Skewness
Style
+1.40
-4.21%
-5.90%
-43.7%
Historical Volatility
Style
+0.90
-12.86%
-11.59%
-85.9%
Specific
Specific
—
—
-19.43%
-143.9%
3. Risk attribution
Annualised volatility is 40.95%; factor risk explains 41.4% of variance and specific risk 58.6%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.
Factor
Type
Exposure
Share of variance
Vol contribution
Share of vol
Specific
Specific
—
58.6%
+23.99%
24.0%
Health Care
Industry
+0.83
11.6%
+4.76%
4.8%
Momentum
Style
+1.12
5.6%
+2.28%
2.3%
Growth
Style
+1.76
5.1%
+2.09%
2.1%
Kurtosis
Style
+2.19
4.7%
+1.91%
1.9%
Historical Volatility
Style
+0.90
3.8%
+1.56%
1.6%
Other
Industry
+0.17
3.6%
+1.49%
1.5%
Liquidity
Style
+1.28
2.8%
+1.16%
1.2%
Short-term Reversal
Style
-1.69
2.5%
+1.01%
1.0%
Max Drawdown
Style
+0.96
1.4%
+0.57%
0.6%
Leverage (Downside Vol)
Style
-0.89
1.3%
+0.52%
0.5%
Size
Style
-0.28
0.4%
+0.16%
0.2%
Mid Cap
Style
+0.30
0.4%
+0.16%
0.2%
Beta
Style
+0.03
0.2%
+0.09%
0.1%
Residual Volatility
Style
-0.56
-0.9%
-0.37%
-0.4%
Skewness
Style
+1.40
-1.0%
-0.41%
-0.4%
4. Style exposures
Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.
Style factor
Portfolio
QQQ benchmark
Difference
Size
-0.28
+2.10
-2.38
Non-linear Size
+0.99
+1.68
-0.68
Mid Cap
+0.30
+0.13
+0.18
Beta
+0.03
+1.29
-1.26
Momentum
+1.12
+0.72
+0.41
Short-term Reversal
-1.69
-0.64
-1.05
Residual Volatility
-0.56
-0.40
-0.16
Historical Volatility
+0.90
+0.86
+0.04
Liquidity
+1.28
+0.11
+1.16
Amihud Illiquidity
+0.73
+1.16
-0.43
Turnover
-0.58
+0.21
-0.78
Growth
+1.76
+0.58
+1.17
Leverage (Downside Vol)
-0.90
+0.14
-1.04
Skewness
+1.40
+0.24
+1.16
Kurtosis
+2.19
+0.21
+1.97
Max Drawdown
+0.96
-0.08
+1.04
5. Industry allocation & Brinson
Sector
Portfolio
Benchmark
Portfolio ret
Benchmark ret
Allocation
Selection
Interaction
Total
Information Technology
0.0%
73.6%
+0.00%
-19.18%
+4.32%
+14.12%
-14.12%
+14.12%
Communication Services
0.0%
2.6%
+0.00%
-15.54%
+0.06%
+0.41%
-0.41%
+0.41%
Other
17.2%
0.0%
+1.65%
+0.00%
+2.28%
+0.00%
+0.28%
+0.28%
Utilities
0.0%
0.8%
+0.00%
+11.58%
-0.20%
-0.09%
+0.09%
-0.09%
Consumer Staples
0.0%
0.8%
+0.00%
+15.58%
-0.24%
-0.13%
+0.13%
-0.13%
Consumer Discretionary
0.0%
8.8%
+0.00%
+5.56%
-1.66%
-0.49%
+0.49%
-0.49%
Industrials
0.0%
11.1%
+0.00%
+7.16%
-2.27%
-0.80%
+0.80%
-0.80%
Health Care
82.8%
1.7%
-15.99%
+9.16%
+18.22%
-0.43%
-20.40%
-13.40%
Total
+20.41%
+12.55%
-33.10%
-0.13%
6. Holdings & contribution
Symbol
Name
Sector
Weight
Return
Contribution
QoQ
NTRA
NATERA INC
Health Care
56.57%
-22.80%
-12.90%
Hold
IWM
ISHARES TR
Other
12.27%
+1.24%
+0.15%
New
AZN
ASTRAZENECA PLC
Health Care
5.46%
+14.23%
+0.78%
New
QQQ
INVESCO QQQ TR
Other
4.90%
+2.69%
+0.13%
New
AVBP
ARRIVENT BIOPHARMA INC
Health Care
4.54%
-57.03%
-2.59%
Hold
LLY
ELI LILLY & CO
Health Care
4.47%
+24.75%
+1.11%
New
NVS
NOVARTIS AG
Health Care
2.48%
+12.58%
+0.31%
New
ALNY
ALNYLAM PHARMACEUTICALS INC
Health Care
2.46%
-33.11%
-0.81%
New
BMY
BRISTOL-MYERS SQUIBB CO
Health Care
1.82%
+2.70%
+0.05%
Reduce
ABT
ABBOTT LABORATORIES
Health Care
1.81%
+9.80%
+0.18%
Add
UTHR
UNITED THERAPEUTICS CORP DEL
Health Care
1.75%
+9.09%
+0.16%
Reduce
IDXX
IDEXX LABS INC
Health Care
1.34%
+34.86%
+0.47%
New
SGMT
SAGIMET BIOSCIENCES INC
Health Care
0.14%
+3.44%
+0.01%
Reduce
Contribution rank
Symbol
Sector
Weight
Return
Contribution
1
LLY
Health Care
4.47%
+24.75%
+1.11%
2
AZN
Health Care
5.46%
+14.23%
+0.78%
3
IDXX
Health Care
1.34%
+34.86%
+0.47%
4
NVS
Health Care
2.48%
+12.58%
+0.31%
5
ABT
Health Care
1.81%
+9.80%
+0.18%
6
UTHR
Health Care
1.75%
+9.09%
+0.16%
7
IWM
Other
12.27%
+1.24%
+0.15%
8
QQQ
Other
4.90%
+2.69%
+0.13%
9
BMY
Health Care
1.82%
+2.70%
+0.05%
10
SGMT
Health Care
0.14%
+3.44%
+0.01%
11
ALNY
Health Care
2.46%
-33.11%
-0.81%
12
AVBP
Health Care
4.54%
-57.03%
-2.59%
13
NTRA
Health Care
56.57%
-22.80%
-12.90%
7. Conclusions
Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned -13.47%, versus -13.72% for the QQQ synthetic benchmark — an excess of +0.25%.
Return attribution: the largest positive style/industry contributions came from Kurtosis +15.24%, Health Care +6.73%, Turnover +2.76%; the largest drags came from Historical Volatility -11.59%, Skewness -5.90%, Momentum -3.75%. Specific (stock-level) return contributed -19.43%.
Risk attribution: Barra model volatility is 40.95% annualised; factor risk explains 41% of variance and specific risk 59%. The largest factor risk sources are Health Care 11.6%, Momentum 5.6%, Growth 5.1%.
Style tilt: size -0.28, momentum +1.12, volatility +0.90, liquidity +1.28; the weighted raw beta is 0.89. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
Industry: the largest overweight versus the benchmark is Health Care (+81.1 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +20.41%, selection +12.55% and interaction -33.10%.
Concentration: the top-10 positions are 96.8% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.
FAQ
What did Sofinnova Investments, Inc. buy in 2026-Q3?
In its 2026-Q3 13F filing, Sofinnova Investments, Inc. reported 63 equity positions worth $2.21B in aggregate; its largest disclosed positions were NTRA ($640.75M), GMAB ($155.17M), IWM ($138.94M).
How large is Sofinnova Investments, Inc.'s portfolio?
Sofinnova Investments, Inc. reported $2.21B of long equity holdings across 63 positions as of 2026-Q3. Top-10 holdings account for 65.9% of reported value.
What is Sofinnova Investments, Inc.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.
Embed this fund on your site
Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.
<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>